HBZ and cancer: (Supplementary Data 4-5) Notably, only 27% (23/84) and 3.5% (3/84) cancer related genes were differentially expressed in ATL-2 and Jurkat-HBZ cells, respectively (|log2FC|>1, p<0.05, Supplementary Figure 4), indicating that the majority of these HBZ splicing targets are not affected in their expression level.